Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
The effect of ophthalmic and systemic formulations of Latilactobacillus sakei on clinical and immunological outcomes of patients with dry eye disease: a factorial, randomized, placebo-controlled, and triple-masking clinical trial
A 2024 commentary in JMIR Diabetes highlighted that as millions more patients start GLP-1 therapy, the "frequent communication, titration, and administrative interactions" could overwhelm healthcare providers, making AI support crucial for comprehensive care.8 Digital health companies are incorporating mood tracking and behavioral health support into their GLP-1 management platforms, using AI to identify patterns that might indicate psychological challenges or needed interventions.4 For example, Lark Health's GLP-1 Companion Program employs AI to provide 24/7 emotional support and coaching, helping patients navigate the psychological aspects of rapid weight loss and lifestyle changes.9 FUTURE DIRECTIONS AND IMPLICATIONS The integration of AI with GLP-1 therapy represents a significant step toward more personalized and effective obesity treatment
Some studies have shown reductions in inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) in patients treated with GLP-1 receptor agonists, though these findings are preliminary and not an indication for use
Obesity Pillars , 17 , 100233
The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality prior to distribution
US$ 28.41
US$ 25.76
US$ 23.03
US$ 26.17
US$ 27.90
US$ 28.27
US$ 24.75
US$ 21.46
